ZA201501772B - Non-invasive determination of methylome of fetus or tumor from plasma - Google Patents
Non-invasive determination of methylome of fetus or tumor from plasmaInfo
- Publication number
- ZA201501772B ZA201501772B ZA2015/01772A ZA201501772A ZA201501772B ZA 201501772 B ZA201501772 B ZA 201501772B ZA 2015/01772 A ZA2015/01772 A ZA 2015/01772A ZA 201501772 A ZA201501772 A ZA 201501772A ZA 201501772 B ZA201501772 B ZA 201501772B
- Authority
- ZA
- South Africa
- Prior art keywords
- methylome
- fetus
- tumor
- plasma
- invasive determination
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 210000003754 fetus Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/10—Characterised by chemical treatment
- C12Q2523/125—Bisulfite(s)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
- C12Q2535/122—Massive parallel sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261703512P | 2012-09-20 | 2012-09-20 | |
| US13/842,209 US9732390B2 (en) | 2012-09-20 | 2013-03-15 | Non-invasive determination of methylome of fetus or tumor from plasma |
| US201361830571P | 2013-06-03 | 2013-06-03 | |
| PCT/AU2013/001088 WO2014043763A1 (en) | 2012-09-20 | 2013-09-20 | Non-invasive determination of methylome of fetus or tumor from plasma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201501772B true ZA201501772B (en) | 2016-10-26 |
Family
ID=50340462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2015/01772A ZA201501772B (en) | 2012-09-20 | 2015-03-16 | Non-invasive determination of methylome of fetus or tumor from plasma |
Country Status (28)
| Country | Link |
|---|---|
| EP (6) | EP3839065A1 (enExample) |
| JP (6) | JP6317354B2 (enExample) |
| KR (5) | KR102307424B1 (enExample) |
| CN (2) | CN117757932A (enExample) |
| AU (5) | AU2013317708C1 (enExample) |
| BR (3) | BR112015006183B1 (enExample) |
| CA (2) | CA2884066C (enExample) |
| CY (1) | CY1124139T1 (enExample) |
| DK (4) | DK3536807T3 (enExample) |
| EA (1) | EA201500327A1 (enExample) |
| ES (4) | ES2862726T3 (enExample) |
| FI (2) | FI3536807T3 (enExample) |
| HR (3) | HRP20241142T1 (enExample) |
| HU (3) | HUE068129T2 (enExample) |
| IL (4) | IL299444B2 (enExample) |
| LT (2) | LT3354747T (enExample) |
| MX (1) | MX360034B (enExample) |
| MY (2) | MY173356A (enExample) |
| NZ (2) | NZ717423A (enExample) |
| PH (2) | PH12015500547B1 (enExample) |
| PL (4) | PL3354747T3 (enExample) |
| PT (4) | PT3354747T (enExample) |
| SG (2) | SG10201705198UA (enExample) |
| SI (1) | SI4056712T1 (enExample) |
| SM (1) | SMT202100256T1 (enExample) |
| TW (5) | TWI784258B (enExample) |
| WO (1) | WO2014043763A1 (enExample) |
| ZA (1) | ZA201501772B (enExample) |
Families Citing this family (94)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101153336B (zh) | 2006-09-27 | 2011-09-07 | 香港中文大学 | 检测dna甲基化程度的方法和试剂盒 |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| US9732390B2 (en) | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
| DK3536807T3 (da) * | 2012-09-20 | 2024-02-05 | Univ Hong Kong Chinese | Ikkeinvasiv bestemmelse af foster- eller tumormethylom fra plasma |
| US10706957B2 (en) | 2012-09-20 | 2020-07-07 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of tumor from plasma |
| US20130309666A1 (en) | 2013-01-25 | 2013-11-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| CN105555965B (zh) * | 2013-07-30 | 2020-06-05 | 深圳华大基因股份有限公司 | 确定核酸混合物中核酸组成的方法 |
| US10174375B2 (en) * | 2013-09-20 | 2019-01-08 | The Chinese University Of Hong Kong | Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases |
| CN106029909B (zh) * | 2014-02-18 | 2021-02-02 | 生物纳米基因公司 | 测定核酸结构信息的改进方法 |
| CN109971852A (zh) * | 2014-04-21 | 2019-07-05 | 纳特拉公司 | 检测染色体片段中的突变和倍性 |
| US12492429B2 (en) | 2014-04-21 | 2025-12-09 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
| SG11201608993RA (en) | 2014-05-09 | 2016-11-29 | Lifecodexx Ag | Detection of dna that originates from a specific cell-type and related methods |
| EP2942400A1 (en) | 2014-05-09 | 2015-11-11 | Lifecodexx AG | Multiplex detection of DNA that originates from a specific cell-type |
| WO2016010401A1 (ko) * | 2014-07-18 | 2016-01-21 | 에스케이텔레콘 주식회사 | 산모의 혈청 dna를 이용한 태아의 단일유전자 유전변이의 예측방법 |
| TWI703216B (zh) | 2014-07-18 | 2020-09-01 | 香港中文大學 | Ｄｎａ混合物中之組織甲基化模式分析 |
| CN107002122B (zh) | 2014-07-25 | 2023-09-19 | 华盛顿大学 | 确定导致无细胞dna的产生的组织和/或细胞类型的方法以及使用其鉴定疾病或紊乱的方法 |
| AU2015374259B2 (en) | 2014-12-31 | 2020-08-13 | Guardant Health, Inc. | Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results |
| US10364467B2 (en) * | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
| EP4012715B1 (en) | 2015-02-10 | 2025-09-24 | The Chinese University Of Hong Kong | Detecting mutations for cancer screening and fetal analysis |
| CA2993588A1 (en) | 2015-07-20 | 2017-01-26 | The Chinese University Of Hong Kong | Methylation pattern analysis of haplotypes in tissues in dna mixture |
| FI3967775T3 (fi) | 2015-07-23 | 2023-09-25 | Univ Hong Kong Chinese | Soluttoman DNA:n fragmentointimallien analyysi |
| TWI728994B (zh) | 2015-08-12 | 2021-06-01 | 香港中文大學 | 血漿ｄｎａ之單分子定序 |
| SG10202107693TA (en) | 2015-09-22 | 2021-09-29 | Univ Hong Kong Chinese | Accurate quantification of fetal dna fraction by shallow-depth sequencing of maternal plasma dna |
| US10260088B2 (en) * | 2015-10-30 | 2019-04-16 | New England Biolabs, Inc. | Compositions and methods for analyzing modified nucleotides |
| CN108368548A (zh) * | 2015-11-09 | 2018-08-03 | 普罗格尼迪公司 | 用于确定dna分子的来源的方法 |
| EP3168309B8 (en) | 2015-11-10 | 2020-06-03 | Eurofins LifeCodexx GmbH | Detection of foetal chromosomal aneuploidies using dna regions that are differentially methylated between the foetus and the pregnant female |
| EP4648053A3 (en) * | 2015-12-17 | 2026-01-07 | Illumina, Inc. | Distinguishing methylation levels in complex biological samples |
| CN109072309B (zh) * | 2016-02-02 | 2023-05-16 | 夸登特健康公司 | 癌症进化检测和诊断 |
| US11514289B1 (en) | 2016-03-09 | 2022-11-29 | Freenome Holdings, Inc. | Generating machine learning models using genetic data |
| EP4425178A3 (en) | 2016-05-03 | 2024-12-18 | University Health Network | Methods of capturing cell-free methylated dna and uses of same |
| EP3452620B1 (en) * | 2016-05-04 | 2025-11-05 | Queen's University at Kingston | Cell-free detection of methylated tumour dna |
| CN115161390B (zh) * | 2016-05-30 | 2025-12-05 | 香港中文大学 | 使用血液中的无细胞dna检测血液病症 |
| JP7066643B2 (ja) * | 2016-06-16 | 2022-05-13 | ザ・ジョンズ・ホプキンス・ユニバーシティ | エピジェネティクス解析の為の方法及びシステム |
| WO2018036537A1 (zh) * | 2016-08-24 | 2018-03-01 | 中国科学院上海生命科学研究院 | Cmd1酶催化的5-甲基胞嘧啶核酸的新修饰及其应用 |
| MY205940A (en) | 2016-10-19 | 2024-11-21 | Univ Hong Kong Chinese | Gestational age assessment by methylation and size profiling of maternal plasma dna |
| MY195527A (en) | 2016-10-24 | 2023-01-30 | Grail Inc | Methods And Systems For Tumor Detection |
| IL266347B2 (en) * | 2016-11-30 | 2025-01-01 | Univ Hong Kong Chinese | Analysis of cell-free DNA in urine and other samples |
| EP3555311B1 (en) * | 2016-12-13 | 2024-06-26 | Bellwether Bio, Inc. | Determining a physiological condition in an individual by analyzing cell-free dna fragment endpoints in a biological sample |
| CA3049442A1 (en) * | 2017-01-11 | 2018-07-19 | Quest Diagnostics Investments Llc | Method for non-invasive prenatal screening for aneuploidy |
| WO2018137496A1 (zh) * | 2017-01-24 | 2018-08-02 | 深圳华大基因股份有限公司 | 确定生物样本中预定来源的游离核酸比例的方法及装置 |
| US10633713B2 (en) | 2017-01-25 | 2020-04-28 | The Chinese University Of Hong Kong | Diagnostic applications using nucleic acid fragments |
| CN107247873B (zh) * | 2017-03-29 | 2020-04-14 | 电子科技大学 | 一种差异甲基化位点识别方法 |
| WO2018209361A2 (en) * | 2017-05-12 | 2018-11-15 | President And Fellows Of Harvard College | Universal early cancer diagnostics |
| JP2020537487A (ja) * | 2017-07-12 | 2020-12-24 | ユニバーシティー ヘルス ネットワーク | メチローム解析を用いる癌の検出及び分類 |
| AU2018300157A1 (en) * | 2017-07-12 | 2020-02-27 | Ande Corporation | Pattern recognition system |
| US12227737B2 (en) | 2017-07-12 | 2025-02-18 | University Health Network | Cancer detection and classification using methylome analysis |
| CN111051536A (zh) | 2017-07-26 | 2020-04-21 | 香港中文大学 | 利用不含细胞的病毒核酸改善癌症筛选 |
| WO2019055819A1 (en) | 2017-09-14 | 2019-03-21 | Grail, Inc. | METHODS FOR PREPARING A SEQUENCING LIBRARY FROM SINGLE STRANDED DNA |
| WO2019067973A1 (en) | 2017-09-28 | 2019-04-04 | Grail, Inc. | ENRICHMENT OF SHORT NUCLEIC ACID FRAGMENTS IN THE PREPARATION OF SEQUENCING LIBRARIES |
| US11168356B2 (en) * | 2017-11-02 | 2021-11-09 | The Chinese University Of Hong Kong | Using nucleic acid size range for noninvasive cancer detection |
| TWI834642B (zh) | 2018-03-13 | 2024-03-11 | 美商格瑞爾有限責任公司 | 異常片段偵測及分類 |
| SG11202008957VA (en) * | 2018-03-15 | 2020-10-29 | Grail Inc | Tissue-specific methylation marker |
| AU2019249422B2 (en) * | 2018-04-02 | 2025-09-25 | GRAIL, Inc | Methylation markers and targeted methylation probe panels |
| SG11202009696WA (en) * | 2018-04-13 | 2020-10-29 | Freenome Holdings Inc | Machine learning implementation for multi-analyte assay of biological samples |
| CN112218957B (zh) * | 2018-04-16 | 2025-08-08 | 格里尔公司 | 用于确定在无细胞核酸中的肿瘤分数的系统及方法 |
| WO2019209884A1 (en) | 2018-04-23 | 2019-10-31 | Grail, Inc. | Methods and systems for screening for conditions |
| US11932899B2 (en) * | 2018-06-07 | 2024-03-19 | 10X Genomics, Inc. | Methods and systems for characterizing nucleic acid molecules |
| CN109448789A (zh) * | 2018-09-17 | 2019-03-08 | 上海派森诺生物科技股份有限公司 | 一种基于perl语言的种群特异SNP位点的自动化分析方法 |
| EP3856903A4 (en) | 2018-09-27 | 2022-07-27 | Grail, LLC | METHYLATION MARKER AND TARGETED METHYLATION PROBE PANEL |
| CN109295230A (zh) * | 2018-10-24 | 2019-02-01 | 福建翊善生物科技有限公司 | 一种基于ctDNA的多基因联合突变检测评估肿瘤动态变化的方法 |
| CA3120713A1 (en) | 2018-11-21 | 2020-05-28 | Avida Biomed, Inc. | Methods for targeted nucleic acid library formation |
| TW202536188A (zh) * | 2018-12-19 | 2025-09-16 | 香港中文大學 | 游離dna末端特徵 |
| EP3899953A1 (en) | 2018-12-21 | 2021-10-27 | Grail, Inc. | Source of origin deconvolution based on methylation fragments in cell-free-dna samples |
| EP3921445B1 (en) | 2019-02-05 | 2024-09-04 | Grail, Inc. | Detecting cancer, cancer tissue of origin, and/or a cancer cell type |
| WO2020163410A1 (en) | 2019-02-05 | 2020-08-13 | Grail, Inc. | Detecting cancer, cancer tissue of origin, and/or a cancer cell type |
| TWI874374B (zh) | 2019-03-25 | 2025-03-01 | 香港中文大學 | 確定循環核酸之線性及環狀形式 |
| US11773450B2 (en) | 2019-04-03 | 2023-10-03 | Grail, Llc | Methylation-based false positive duplicate marking reduction |
| BR112021022084A2 (pt) * | 2019-05-03 | 2022-02-08 | Univ Cornell | Marcadores para identificar e quantificar a mutação da sequência de ácido nucleico, expressão, variante de splice, translocação, número de cópias ou alterações de metilação |
| KR102452413B1 (ko) * | 2019-08-19 | 2022-10-11 | 주식회사 지씨지놈 | 핵산 단편간 거리 정보를 이용한 염색체 이상 검출 방법 |
| US20230178182A1 (en) * | 2019-08-19 | 2023-06-08 | Green Cross Genome Corporation | Method for detecting chromosomal abnormality by using information about distance between nucleic acid fragments |
| GB201915469D0 (en) | 2019-10-24 | 2019-12-11 | Univ London | Cancer detection methods |
| AU2020391488A1 (en) * | 2019-11-27 | 2022-06-09 | GRAIL, Inc | Systems and methods for evaluating longitudinal biological feature data |
| EP4097231B1 (en) | 2020-01-31 | 2025-03-19 | Agilent Technologies, Inc. | Systems and methods for targeted nucleic acid capture |
| WO2021163163A1 (en) * | 2020-02-10 | 2021-08-19 | Palogen, Inc. | Nanopore device and methods of detecting and classifying charged particles using same |
| US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
| US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
| US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
| EP4111457A1 (en) * | 2020-02-28 | 2023-01-04 | Grail, LLC | Identifying methylation patterns that discriminate or indicate a cancer condition |
| CN112662764A (zh) * | 2020-03-17 | 2021-04-16 | 博尔诚（北京）科技有限公司 | 一种检测11种癌症的探针组合物 |
| RU2738675C1 (ru) * | 2020-07-28 | 2020-12-15 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ прогнозирования риска развития преэклампсии у женщин без отягощенного семейного анамнеза с учетом генетических факторов |
| EP4247973A4 (en) * | 2020-11-19 | 2024-09-11 | Nucleix Ltd. | DETECTION OF METHYLATION CHANGES IN DNA SAMPLES USING RESTRICTION ENZYMES AND HIGH-THROUGHPUT SEQUENCING |
| EP4263874A4 (en) * | 2020-12-17 | 2024-11-06 | President and Fellows of Harvard College | METHODS FOR DETECTING CANCER USING EXTRA-EMBRYONIC METHYLATED CPG ISLETS |
| CN112813148A (zh) * | 2021-02-02 | 2021-05-18 | 博淼生物科技（北京）有限公司 | 飞行时间质谱检测5-羟甲基胞嘧啶的方法 |
| CN118302816A (zh) * | 2021-09-28 | 2024-07-05 | 行动基因(智财)有限公司 | 甲基化生物标记选择装置及方法 |
| KR20230059423A (ko) * | 2021-10-26 | 2023-05-03 | 주식회사 지씨지놈 | 메틸화된 무세포 핵산을 이용한 암 진단 및 암 종 예측방법 |
| TW202321464A (zh) * | 2021-11-04 | 2023-06-01 | 西班牙商通用診斷股份公司 | 製備用於基因定序之生物樣本的系統與方法 |
| EP4534686A3 (en) | 2022-02-07 | 2025-07-16 | Centre for Novostics | Fragmentation for measuring methylation and disease |
| US20240150840A1 (en) * | 2022-02-22 | 2024-05-09 | Flagship Pioneering Innovations Vi, Llc | Intra-individual analysis for presence of health conditions |
| CN115064211B (zh) * | 2022-08-15 | 2023-01-24 | 臻和(北京)生物科技有限公司 | 一种基于全基因组甲基化测序的ctDNA预测方法及装置 |
| CN115612723B (zh) * | 2022-09-26 | 2023-07-14 | 广州女娲生命科技有限公司 | 植入前胚胎的筛选方法 |
| WO2024203348A1 (ja) * | 2023-03-31 | 2024-10-03 | ソニーグループ株式会社 | 腫瘍の解析方法、腫瘍の解析システム、及び腫瘍の解析データ生成方法 |
| CN116555426B (zh) * | 2023-05-04 | 2024-07-12 | 杭州圣庭医疗科技有限公司 | 一种鉴定肿瘤组织来源的试剂盒及数据分析方法 |
| CN117025753A (zh) * | 2023-08-15 | 2023-11-10 | 广州女娲生命科技有限公司 | 检测染色体变异的方法和装置 |
| CN117079822B (zh) * | 2023-10-17 | 2024-01-02 | 北京大学第三医院（北京大学第三临床医学院） | 一种妊娠早中期四因子预测胎儿脑损伤的系统 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6927028B2 (en) * | 2001-08-31 | 2005-08-09 | Chinese University Of Hong Kong | Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA |
| ES2253461T3 (es) † | 2002-03-05 | 2006-06-01 | Epigenomics Ag | Procedimiento y dispositivo para la determinacion de la especificidad del tejido y del adn que flota libre en tejidos corporales. |
| WO2004046332A2 (en) † | 2002-11-19 | 2004-06-03 | Amgen Inc. | Amplified genes involved in cancer |
| US20060183128A1 (en) † | 2003-08-12 | 2006-08-17 | Epigenomics Ag | Methods and compositions for differentiating tissues for cell types using epigenetic markers |
| DE10348407A1 (de) | 2003-10-17 | 2005-05-19 | Widschwendter, Martin, Prof. | Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben |
| EP1725682B1 (en) | 2004-03-08 | 2015-09-09 | Rubicon Genomics, Inc. | Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation |
| JP2008545418A (ja) | 2005-05-27 | 2008-12-18 | ジョン ウェイン キャンサー インスティチュート | 癌の診断、予後診断、および治療のための遊離循環ｄｎａの使用 |
| US7901884B2 (en) * | 2006-05-03 | 2011-03-08 | The Chinese University Of Hong Kong | Markers for prenatal diagnosis and monitoring |
| US7754428B2 (en) * | 2006-05-03 | 2010-07-13 | The Chinese University Of Hong Kong | Fetal methylation markers |
| CN101153336B (zh) * | 2006-09-27 | 2011-09-07 | 香港中文大学 | 检测dna甲基化程度的方法和试剂盒 |
| EP2173897A2 (en) | 2007-06-19 | 2010-04-14 | Oncomethylome Sciences SA | Improved urine sample collecting and processing |
| EP2557520B1 (en) | 2007-07-23 | 2021-04-07 | The Chinese University of Hong Kong | Determining a nucleic acid sequence imbalance |
| JP4347372B2 (ja) | 2007-08-10 | 2009-10-21 | トヨタ自動車株式会社 | 静電塗装装置 |
| US20110028333A1 (en) * | 2009-05-01 | 2011-02-03 | Brown University | Diagnosing, prognosing, and early detection of cancers by dna methylation profiling |
| US8563242B2 (en) * | 2009-08-11 | 2013-10-22 | The Chinese University Of Hong Kong | Method for detecting chromosomal aneuploidy |
| US20120208711A1 (en) * | 2009-10-02 | 2012-08-16 | Centre For Addiction And Mental Health | Method for Analysis of DNA Methylation Profiles of Cell-Free Circulating DNA in Bodily Fluids |
| TWI458976B (zh) * | 2009-11-05 | 2014-11-01 | Univ Hong Kong Chinese | 由母體之生物樣本分析胎兒之基因體 |
| EP2496713B1 (en) | 2009-11-06 | 2018-07-18 | The Chinese University of Hong Kong | Size-based genomic analysis |
| AU2011207544A1 (en) † | 2010-01-19 | 2012-09-06 | Verinata Health, Inc. | Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing |
| PL2529032T3 (pl) † | 2010-01-26 | 2017-07-31 | Nipd Genetics Ltd | Sposoby i kompozycje do nieinwazyjnego prenatalnego diagnozowania aneuploidii płodu |
| CN110322924A (zh) † | 2010-04-29 | 2019-10-11 | 加利福尼亚大学董事会 | 利用关于基因组模型的数据集成的途径识别方法(paradigm) |
| GB201007944D0 (en) * | 2010-05-12 | 2010-06-30 | Univ Aberystwyth | Methods |
| US10167513B2 (en) | 2010-05-25 | 2019-01-01 | The Johns Hopkins University | Compositions and methods for detecting a neoplasia |
| US20120053073A1 (en) * | 2010-07-23 | 2012-03-01 | President And Fellows Of Harvard College | Methods for Detecting Signatures of Disease or Conditions in Bodily Fluids |
| JP2013530727A (ja) * | 2010-07-23 | 2013-08-01 | エソテリックス ジェネティック ラボラトリーズ， エルエルシー | 差次的に提示される胎児のゲノム領域もしくは母親のゲノム領域の同定およびそれらの使用 |
| WO2012031329A1 (en) † | 2010-09-10 | 2012-03-15 | Murdoch Childrens Research Institute | Assay for detection and monitoring of cancer |
| TWI642786B (zh) † | 2010-11-30 | 2018-12-01 | 香港中文大學 | 與癌症有關之基因或分子變異之檢測 |
| DK3536807T3 (da) * | 2012-09-20 | 2024-02-05 | Univ Hong Kong Chinese | Ikkeinvasiv bestemmelse af foster- eller tumormethylom fra plasma |
-
2013
- 2013-09-20 DK DK19171630.7T patent/DK3536807T3/da active
- 2013-09-20 HR HRP20241142TT patent/HRP20241142T1/hr unknown
- 2013-09-20 EP EP21151739.6A patent/EP3839065A1/en active Pending
- 2013-09-20 NZ NZ717423A patent/NZ717423A/en unknown
- 2013-09-20 DK DK22171427.2T patent/DK4056712T3/da active
- 2013-09-20 BR BR112015006183-4A patent/BR112015006183B1/pt active IP Right Grant
- 2013-09-20 MY MYPI2015000628A patent/MY173356A/en unknown
- 2013-09-20 MY MYPI2018000607A patent/MY187444A/en unknown
- 2013-09-20 KR KR1020207019527A patent/KR102307424B1/ko active Active
- 2013-09-20 ES ES17202149T patent/ES2862726T3/es active Active
- 2013-09-20 ES ES13838770T patent/ES2665273T5/es active Active
- 2013-09-20 ES ES22171427T patent/ES2994426T3/es active Active
- 2013-09-20 IL IL299444A patent/IL299444B2/en unknown
- 2013-09-20 SG SG10201705198UA patent/SG10201705198UA/en unknown
- 2013-09-20 DK DK17202149.5T patent/DK3354747T3/da active
- 2013-09-20 PL PL17202149T patent/PL3354747T3/pl unknown
- 2013-09-20 PH PH1/2015/500547A patent/PH12015500547B1/en unknown
- 2013-09-20 EP EP13838770.9A patent/EP2898100B9/en active Active
- 2013-09-20 CA CA2884066A patent/CA2884066C/en active Active
- 2013-09-20 PL PL13838770.9T patent/PL2898100T5/pl unknown
- 2013-09-20 EP EP17202149.5A patent/EP3354747B1/en not_active Revoked
- 2013-09-20 PT PT172021495T patent/PT3354747T/pt unknown
- 2013-09-20 EP EP19171630.7A patent/EP3536807B1/en active Active
- 2013-09-20 PL PL19171630.7T patent/PL3536807T3/pl unknown
- 2013-09-20 KR KR1020237033920A patent/KR20230145530A/ko not_active Ceased
- 2013-09-20 HU HUE22171427A patent/HUE068129T2/hu unknown
- 2013-09-20 FI FIEP19171630.7T patent/FI3536807T3/fi active
- 2013-09-20 NZ NZ706269A patent/NZ706269A/en unknown
- 2013-09-20 SM SM20210256T patent/SMT202100256T1/it unknown
- 2013-09-20 PT PT221714272T patent/PT4056712T/pt unknown
- 2013-09-20 ES ES19171630T patent/ES2969567T3/es active Active
- 2013-09-20 WO PCT/AU2013/001088 patent/WO2014043763A1/en not_active Ceased
- 2013-09-20 CN CN202311671688.1A patent/CN117757932A/zh active Pending
- 2013-09-20 SI SI201332088T patent/SI4056712T1/sl unknown
- 2013-09-20 LT LTEP17202149.5T patent/LT3354747T/lt unknown
- 2013-09-20 EP EP22171427.2A patent/EP4056712B1/en active Active
- 2013-09-20 FI FIEP22171427.2T patent/FI4056712T3/fi active
- 2013-09-20 DK DK13838770.9T patent/DK2898100T4/da active
- 2013-09-20 MX MX2015003571A patent/MX360034B/es active IP Right Grant
- 2013-09-20 PT PT191716307T patent/PT3536807T/pt unknown
- 2013-09-20 CN CN201380058654.3A patent/CN104781422B/zh active Active
- 2013-09-20 AU AU2013317708A patent/AU2013317708C1/en active Active
- 2013-09-20 KR KR1020217030373A patent/KR102390711B1/ko active Active
- 2013-09-20 IL IL313451A patent/IL313451A/en unknown
- 2013-09-20 LT LTEP22171427.2T patent/LT4056712T/lt unknown
- 2013-09-20 HR HRP20240210TT patent/HRP20240210T1/hr unknown
- 2013-09-20 HU HUE19171630A patent/HUE066054T2/hu unknown
- 2013-09-20 HU HUE17202149A patent/HUE053822T2/hu unknown
- 2013-09-20 BR BR122021021823-4A patent/BR122021021823B1/pt active IP Right Grant
- 2013-09-20 JP JP2015532250A patent/JP6317354B2/ja active Active
- 2013-09-20 PH PH1/2022/552061A patent/PH12022552061A1/en unknown
- 2013-09-20 PL PL22171427.2T patent/PL4056712T3/pl unknown
- 2013-09-20 EP EP24153604.4A patent/EP4335929B1/en active Active
- 2013-09-20 PT PT138387709T patent/PT2898100T/pt unknown
- 2013-09-20 EA EA201500327A patent/EA201500327A1/ru unknown
- 2013-09-20 SG SG11201501927VA patent/SG11201501927VA/en unknown
- 2013-09-20 CA CA3122779A patent/CA3122779A1/en active Pending
- 2013-09-20 BR BR122021021825-0A patent/BR122021021825B1/pt active IP Right Grant
- 2013-09-20 KR KR1020227013227A patent/KR102587176B1/ko active Active
- 2013-09-20 KR KR1020157010184A patent/KR102148547B1/ko active Active
- 2013-09-23 TW TW109112451A patent/TWI784258B/zh active
- 2013-09-23 TW TW107123815A patent/TWI707953B/zh active
- 2013-09-23 TW TW112118074A patent/TWI901957B/zh active
- 2013-09-23 TW TW111119079A patent/TWI806621B/zh active
- 2013-09-23 TW TW102134227A patent/TWI640634B/zh active
-
2015
- 2015-03-02 IL IL237495A patent/IL237495B/en active IP Right Grant
- 2015-03-16 ZA ZA2015/01772A patent/ZA201501772B/en unknown
-
2017
- 2017-10-27 AU AU2017251832A patent/AU2017251832B2/en active Active
-
2018
- 2018-03-28 JP JP2018061744A patent/JP6683752B2/ja active Active
-
2019
- 2019-08-05 IL IL268512A patent/IL268512B2/en unknown
-
2020
- 2020-01-08 AU AU2020200128A patent/AU2020200128B2/en active Active
- 2020-03-26 JP JP2020055387A patent/JP6985753B2/ja active Active
-
2021
- 2021-05-07 HR HRP20210716TT patent/HRP20210716T1/hr unknown
- 2021-05-14 CY CY20211100417T patent/CY1124139T1/el unknown
- 2021-11-18 JP JP2021188060A patent/JP2022031753A/ja active Pending
-
2022
- 2022-02-16 AU AU2022201026A patent/AU2022201026B2/en active Active
-
2023
- 2023-09-28 JP JP2023167714A patent/JP7594817B2/ja active Active
-
2024
- 2024-11-18 JP JP2024200780A patent/JP2025026936A/ja active Pending
-
2025
- 2025-07-03 AU AU2025205087A patent/AU2025205087A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268512A (en) | Non-invasive determination of fetal or tumor methylation from plasma | |
| IL238254A0 (en) | Cancer treatment methods | |
| IL232530A0 (en) | Combined cancer treatment | |
| SG10201508495VA (en) | Combination treatment of cancer | |
| IL228430A0 (en) | Cancer treatment | |
| EP2903644A4 (en) | TREATMENT OF CANCER | |
| GB201217892D0 (en) | Treatment of cancer | |
| PL2855475T3 (pl) | Alfa-karboliny do leczenia nowotworu | |
| GB201217890D0 (en) | Treatment of cancer | |
| GB201222949D0 (en) | Combination Treatment of Cancer | |
| GB201222950D0 (en) | Combination treatment of cancer | |
| GB201222952D0 (en) | Treatent of cancer | |
| GB201208296D0 (en) | Treatment of cancer | |
| GB201121791D0 (en) | Combination treatment of cancer | |
| IL229109B (en) | Cancer diagnosis | |
| GB201017356D0 (en) | Combination treatment of cancer | |
| GB201017354D0 (en) | Treatment of cancer | |
| GB201200263D0 (en) | Detection of breast cancer | |
| GB201121783D0 (en) | Treatment of cancer | |
| GB201200262D0 (en) | Therapy of breast cancer | |
| IL223237A0 (en) | Diagnosis of cancer |